汇添富国证港股通创新药ETF发起式联接A (021030.jj ) 港股通创新药 (半年) 汇添富基金管理股份有限公司申 | 基金类型指数型基金(ETF,联接型)成立日期2024-04-19总资产规模 (2025-09-30) 基金净值1.7974元 (2025-12-19) 基金经理乐无穹孙浩管理费用率0.50%管托费用率0.10% (2025-06-30) 成立以来分红再投入年化收益率42.16% (207 / 5460) |
| 相关基金: | 主从基金: 汇添富国证港股通创新药ETF发起式联接C目标基金: 汇添富国证港股通创新药ETF |
| 备注 (1): | 双击编辑备注 |
汇添富国证港股通创新药ETF发起式联接A(021030) - 基金对比
最后更新于：2025-12-19
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 汇添富国证港股通创新药ETF发起式联接A - 相对起始点分红再投入收益率 | 港股通创新药 - 相对起始点收益率 |
|---|---|---|
| 2025-12-19 | 79.74% | 69.61% |
| 2025-12-18 | 77.32% | 67.03% |
| 2025-12-17 | 76.44% | 66.14% |
| 2025-12-16 | 75.92% | 65.53% |
| 2025-12-15 | 77.08% | 66.77% |
| 2025-12-12 | 84.94% | 74.56% |
| 2025-12-11 | 82.27% | 71.62% |
| 2025-12-10 | 82.90% | 72.10% |
| 2025-12-09 | 84.14% | 73.31% |
| 2025-12-08 | 86.69% | 76.07% |
| 2025-12-05 | 90.22% | 79.69% |
| 2025-12-04 | 90.04% | 79.54% |
| 2025-12-03 | 86.48% | 75.87% |
| 2025-12-02 | 89.66% | 79.12% |
| 2025-12-01 | 92.29% | 81.83% |
| 2025-11-28 | 93.19% | 82.51% |
| 2025-11-27 | 94.80% | 84.10% |
| 2025-11-26 | 93.13% | 82.31% |
| 2025-11-25 | 89.79% | 79.03% |
| 2025-11-24 | 88.88% | 78.11% |
| 2025-11-21 | 83.24% | 72.36% |
| 2025-11-20 | 91.70% | 80.88% |
| 2025-11-19 | 90.16% | 79.37% |
| 2025-11-18 | 91.42% | 80.40% |
| 2025-11-17 | 94.44% | 83.48% |
| 2025-11-14 | 98.25% | 87.31% |
| 2025-11-13 | 99.07% | 88.03% |
| 2025-11-12 | 90.69% | 79.69% |
| 2025-11-11 | 85.99% | 74.90% |
| 2025-11-10 | 86.32% | 75.35% |
| 2025-11-07 | 83.85% | 72.82% |
| 2025-11-06 | 88.41% | 77.37% |
| 2025-11-05 | 87.71% | 76.58% |
| 2025-11-04 | 86.92% | 75.67% |
| 2025-11-03 | 92.35% | 81.33% |
| 2025-10-31 | 88.42% | 77.15% |
| 2025-10-30 | 82.10% | 70.82% |
| 2025-10-29 | 85.35% | -- |
| 2025-10-28 | 85.40% | 74.10% |
| 2025-10-27 | 87.67% | 76.37% |
| 2025-10-24 | 86.24% | 74.91% |
| 2025-10-23 | 86.02% | 74.71% |
| 2025-10-22 | 89.73% | 78.38% |
| 2025-10-21 | 94.04% | 82.76% |
| 2025-10-20 | 93.86% | 82.47% |
| 2025-10-17 | 92.34% | 81.01% |
| 2025-10-16 | 98.38% | 87.33% |
| 2025-10-15 | 94.20% | 82.90% |
| 2025-10-14 | 89.90% | 78.60% |
| 2025-10-13 | 99.21% | 88.18% |